M T Trese1. 1. Associated Retinal Consultants, PC Chief Vitreoretinal Surgery Department of Ophthalmology William Beaumont Hospital Royal Oak, Michigan 48073, USA. MGJT46@aol.com
Abstract
PURPOSE: This paper discusses the approach of enzymatic vitrectomy and potential applications. METHODS: A description of available agents for enzymatic vitreous surgery will be given and the techniques that have been suggested. RESULTS: Both animal and human results will be presented in this article regarding trials of enzymatic vitreous surgery. CONCLUSION: Enzymatic vitreous surgery may be a useful adjunct or additional agent to treat several vitreoretinal diseases.
PURPOSE: This paper discusses the approach of enzymatic vitrectomy and potential applications. METHODS: A description of available agents for enzymatic vitreous surgery will be given and the techniques that have been suggested. RESULTS: Both animal and human results will be presented in this article regarding trials of enzymatic vitreous surgery. CONCLUSION: Enzymatic vitreous surgery may be a useful adjunct or additional agent to treat several vitreoretinal diseases.
Authors: Polly A Quiram; Victor R Leverenz; Robert M Baker; Loan Dang; Frauk J Giblin; Michael T Trese Journal: Retina Date: 2007-10 Impact factor: 4.256
Authors: Francisco R Stefanini; Maurício Maia; Paulo Falabella; Marcel Pfister; Moritz Niemeyer; Amir H Kashani; Mark S Humayun; Michael J Koss Journal: Clin Ophthalmol Date: 2014-05-06
Authors: Laura Bianchi; Annalisa Altera; Virginia Barone; Denise Bonente; Tommaso Bacci; Elena De Benedetto; Luca Bini; Gian Marco Tosi; Federico Galvagni; Eugenio Bertelli Journal: Cells Date: 2022-08-15 Impact factor: 7.666